Перейти к основной навигации
Перейти к поиску
Перейти к основному содержанию
Сортировать по:
INIS
patients
100%
diseases
93%
kazakhstan
58%
reviews
50%
data
48%
risks
43%
proteins
39%
cancer
39%
populations
35%
levels
34%
women
30%
mortality
29%
humans
27%
genes
26%
kidneys
25%
control
23%
children
23%
hospitals
22%
comparative evaluations
22%
management
22%
death
21%
hiv
20%
therapy
20%
covid-19
19%
surgery
19%
heterochromatin
17%
drugs
17%
tissues
15%
inflammation
14%
values
13%
pain
13%
tumors
12%
mice
12%
pregnancy
12%
females
12%
pediatrics
12%
viruses
12%
genetics
12%
injuries
11%
saudi arabia
11%
adults
11%
stem cells
11%
interventions
11%
assessments
11%
losses
11%
epidemiology
11%
males
10%
asia
10%
liver
10%
design
10%
applications
9%
people
9%
surveys
9%
hepatitis
9%
screening
9%
income
9%
interactions
9%
blood
9%
diabetes mellitus
9%
histones
9%
detection
9%
attitudes
9%
learning
9%
vaccines
8%
in vitro
8%
concentration
8%
sex
8%
policy
8%
coronaviruses
8%
distribution
8%
units
8%
universities
7%
receptors
7%
chromatin
7%
education
7%
evaluation
7%
information
7%
sampling
7%
doses
7%
pakistan
7%
cost
7%
biological markers
7%
wounds
7%
guidelines
6%
regulations
6%
quality of life
6%
healing
6%
tuberculosis
6%
antigens
6%
antibodies
6%
etiology
6%
glucose
6%
correlations
6%
tools
6%
dna
6%
antibiotics
6%
ovaries
6%
molecules
6%
medicine
6%
nervous system diseases
6%
Keyphrases
Kazakhstan
54%
COVID-19
25%
Global Burden
20%
Regional Burden
16%
Meta-analysis
15%
National Burden
15%
Risk Factors
14%
Global Burden of Disease 2021
13%
Global Burden of Disease Study
13%
Disability-adjusted Life Years
11%
Saudi Arabia
10%
Chronic Kidney Disease
9%
Heterochromatin Proteins
9%
Electronic Health System
9%
Central Asia
8%
Nursing Students
8%
Heterochromatin
7%
Mortality Rate
7%
Epidemiology
7%
Diabetes
6%
Etiology
6%
Pakistan
6%
Human Immunodeficiency Virus Type 1 (HIV-1)
6%
Endometriosis
6%
Uncertainty Interval
6%
Global Burden of Disease Study 2019
5%
Mycobacterium Tuberculosis (M. tb)
5%
Years Lived with Disability
5%
Kazakh
5%
All-cause Mortality
5%